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Background and Purpose  Identifying changes in the prevalence, disability, and manage-
ment patterns of migraine is important for reducing the burden of this disease. However, data 
on the changes in these variables are scarce.
Methods  We compared data obtained in the 2009 Korean Headache Survey and the 2018 
Korean Sleep-Headache Survey.
Results  The 1-year migraine prevalence did not differ significantly between 2018 and 2009 
[5.2% (114/2,200) vs. 6.0% (91/1,507), p=0.492]. The number of days with missed activity due 
to headache during the previous 3 months was larger in the 2018 survey than in the 2009 sur-
vey [1.1±2.9 vs. 0.3±1.0 days (mean±standard deviation), p=0.013]. The number of days with 
reduced productivity during the previous 3 months did not differ significantly between the 
two surveys (0.8±2.8 vs. 1.4±1.4 days, p=0.679). The proportion of subjects with a substantial-
to-severe headache impact (Headache Impact Test-6 score ≥56) was marginally larger in the 
2018 survey than in the 2009 survey [42.1% (48/114) vs. 29.7% (27/91), p=0.066]. The rate of 
lifetime medical consultations did not differ between the 2018 and 2009 surveys [34.2% (39/ 
114) vs. 30.8% (28/91), p=0.615].
Conclusions  Migraine prevalence was stable over the 9-year period between the surveys, but 
disability due to missed activity was greater in 2018 than in 2009 in Korea.
Key Words   migraine, prevalence, disability evaluation, epidemiology, headache.
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INTRODUCTION
Migraine is a highly prevalent neurological disorder that imposes a large burden on the 
general public. Individuals with migraine may experience various types of disability, such 
as absenteeism or decreased productivity at work, school, and in the household.1 Although 
migraine was found to be the second cause of disability among 328 disorders in the Glob-
al Burden of Diseases studies performed in 1990, 2006, and 2016, its prevalence and dis-
ability have changed considerably over time.2,3 Its prevalence and the associated disability 
are the two most important factors that determine the burden of migraine, and so estimat-
ing changes in these parameters could be useful for developing strategies to reduce the bur-
den of migraine.
Some studies have provided serial data on the prevalence of migraine in the same pop-
ulation,4-8 but the findings have varied. The migraine prevalence has generally been found 
to be stable, but some studies have found significant changes over time. The use of compa-
rable methodologies is required to reliably compare prevalence between surveys. To date, 
only a few studies have replicated surveys of the prevalence of migraine using comparable 
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methodologies. Furthermore, even fewer studies have exam-
ined serial changes in disability or the impact of headaches 
caused by migraine, along with its prevalence.6,7
Advances in the diagnosis and treatment of migraine have 
provided opportunities to reduce its burden. Previous stud-
ies have revealed that migraine has historically been under-
diagnosed and undertreated.4 Recent studies on migraine 
management found increases in medical consultations and 
changes in treatment patterns.4,9 Nevertheless, most of these 
studies were conducted in North American and European 
countries, and data from other regions are scarce. 
The enormous burden of migraine makes reducing mi-
graine-related disability an urgent public health concern. 
Identifying the cumulative effects and pattern of changes in 
migraine-related disability will lead to a better understand-
ing of this debilitating disorder. A better understanding of 
migraine-related disability will enable medical professionals 
to provide migraine patients with coping mechanisms to re-
duce their migraine-related disability.10 
The Korean Headache Survey in 2009 and the Korean 
Sleep-Headache Survey in 2018 provided an opportunity to 
investigate changes in the prevalence, disability, and man-
agement patterns of migraine over a 9-year timespan. Both 
surveys used the same strategies for assessing migraine prev-
alence, the disability and impact of headache, medical con-
sultations, and treatment patterns, and adopted a two-stage 
clustered random sampling method, although they differed 
in their target sample numbers. We compared the data from 
these surveys based on the hypothesis that these factors did 
not differ between 2009 and 2018 in Korea. The aim of the 
present study was to determine the changes in the prevalence, 
disability, medical consultations, and treatment patterns of 
migraine between 2009 and 2018. 
METHODS
Korean Headache Survey in 2009
The Korean Headache Survey in 2009 was a nationwide, cross- 
sectional survey of primary headaches, including migraine. 
We have previously described the sampling and survey pro-
cesses.11,12 In brief, we used a two-stage cluster random sam-
pling method proportional to the population distribution of 
all Korean territories except Jeju-do, based on data from the 
2005 population and the housing census performed by the 
National Statistical Office.13 Korea is geographically divided 
into 15 administrative divisions, which were designated as 
primary sampling units. In the second stage, we further se-
lected representative basic administrative units from each 
primary sampling unit. Overall, 60 representative basic ad-
ministrative units were selected for inclusion in this study. 
For each representative basic administrative unit, we assigned 
a target sample size based on age, sex, and education level. 
The target sample size was 1,500 and the estimated sampling 
error was ≤2.5%. 
The survey was conducted by door-to-door visits and face-
to-face interviews with questionnaires among adults aged 
19–69 years. The interviewers were not medical personnel 
and had previous experience of performing social surveys. 
All interviewers were employees of Gallup Korea (Seoul, 
Korea). The questionnaire was designed to assess demo-
graphic characteristics, headache profiles, headache diagno-
ses, use of medical services, medical consultations, disability 
from headache, and impact of headache. The Korean Head-
ache Survey was performed in March 2009 in accordance 
with the ethical guidelines of the Council for International 
Organizations of Medical Sciences and the principles in the 
Declaration of Helsinki.14 Written informed consent was ob-
tained from all participants before the survey. 
Korean Sleep-Headache Survey in 2018
The Korean Sleep-Headache Survey in 2018 was also a na-
tionwide, cross-sectional survey of primary headaches. The 
sampling and survey processes were the same as those in 
the 2009 survey, with only the target sample number differ-
ing. Two-stage clustered random sampling was performed 
based on the data from the 2017 population and housing cen-
sus conducted by the National Statistical Office of Korea.13 
The target sample size in the 2018 survey was 2,500 adults 
aged 19 years or older, and the estimated sampling error was 
≤1.9%. We selected the data of 2,200 adults aged 19–69 years 
from the 2018 survey to match the age group in the 2009 sur-
vey. The representativeness of our sample was assessed by 
comparing demographic distributions between our samples 
and the total population of Korea in 2018 (Supplementary 
Table 1 in the online-only Data Supplement). 
Like for the 2009 survey, the 2018 survey was conducted 
by Gallup Korea through door-to-door visits and face-to-face 
interviews using a questionnaire. The questionnaire items for 
evaluating the disability from headache, impact of headache, 
medical consultations, and treatment pattern were the same 
as those in 2009 survey. The 2018 survey was approved by 
the Institutional Review Board of Severance Hospital, Yon-
sei University (Approval No. 2018-1269-001). The present 
study was approved by the Institutional Review Board of 
Severance Hospital, Yonsei University (Approval No. 2019-
1721-001). Written informed consents were obtained from 
all participants before the surveys. 
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Diagnosis, impact, disability, and management 
patterns of migraine
Migraine was diagnosed based on the diagnostic criteria for 
migraine without aura in the second edition of the Interna-
tional Classification of Headache Disorders (code 1.1), which 
was the valid scale at the time of the surveys.15 We did not as-
sess the presence of aura because it this is very difficult to 
evaluate in an epidemiological study.16 Therefore, “migraine” 
herein includes migraine with and without aura as reported 
in the 2009 and 2018 surveys. The diagnostic validity of our 
questionnaire has been previously reported.11 If a participant 
responded positively to the question “Did you have headache 
during the previous year?” and their headache fulfilled the 
criteria of migraine, we classified them as a case of migraine.
The impact of headache was investigated using the Head-
ache Impact Test-6 (HIT-6). We classified the impact of head-
ache based on the HIT-6 score as follows: <50, little or no im-
pact; 50–55, some impact; 56–59, substantial impact; and ≥60, 
severe impact.17,18
Disability from migraine was assessed using the following 
two questions: 1) “On how many days in the last 3 months did 
you miss work, school, or housework because of your head-
aches?” and 2) “On how many days in the last 3 months was 
your productivity for work, school, or housework reduced 
by half or more because of your headaches? (Do not include 
days you counted in the question about missing work, school, 
or housework).” 
Lifetime medical consultations for headache were evalu-
ated using the question “Did you ever visit a doctor for your 
headaches?” If the participant responded positively, they were 
classified as having lifetime medical consultations for head-
ache. Treatment patterns for headache were assessed using 
the question “How are you treating your headaches? Please 
select all treatments you have used in the past year: 1) no 
treatment, 2) treatment with over-the-counter (OTC) medi-
cations, 3) visiting traditional Korean medical clinics, 4) al-
ternative methods other than traditional medicine, and 5) vis-
iting clinics or hospitals.” 
Statistical analyses
The primary analysis performed in this study was compar-
ing the variables between the 2009 survey and 2018 survey. 
The 1-year prevalence of migraine was compared between 
the 2009 survey and 2018 survey as the number of cases per 
100 persons. Binary and ordinal variables are presented as 
numbers and percentages, while interval variables are rep-
resented as mean±standard-deviation or median and inter-
quartile-range values, as appropriate. The normality of the 
ratio of variables was tested using the Kolmogorov-Smirnov 
test. Independent two-tailed t-tests or one-way analyses of 
variance were used for intergroup comparisons of variables 
that conformed to a normal distribution. Two-tailed Mann-
Whitney U tests or Kruskal-Wallis tests were used for vari-
ables that did not conform to a normal distribution. 
Since the prevalence of and disability from migraine var-
ied significantly according to sex and age, we compared data 
between the 2009 survey and 2018 survey while adjusting 
for these variables.3,19 The categorical variables were com-
pared between the 2009 survey and 2018 survey using logis-
tic regression analyses while adjusting for age (in years, as a 
continuous variable) and sex. Linear regression analyses while 
adjusting for age and sex were used for comparing numeri-
cal variables between the surveys. The Statistical Package for 
Social Sciences (version 24.0, IBM, Armonk, NY, USA) was 
used for all statistical analyses. The criterion for statistical 
significance was set as p<0.05. 
We used the weighted values of participants based on clus-
tered sampling processes in the analyses. Weighted values were 
determined by dividing the actual number of participants by 
the number of target samples allocated at each survey unit. 
As with most survey studies, there were missing data due to 
nonresponses for several variables. The reported data are 
based on the available data; imputation techniques were not 
employed in order to minimize any effects of nonresponses.20 
RESULTS
Sample and survey 
The 2009 and 2018 surveys were completed by 1,507 and 
2,200 individuals aged 19–69 years, respectively. The sex and 
age distributions of our samples in 2009 and 2018 did not 
differ significantly from those in the total Korean popula-
tions in 2009 and 2018 (Supplementary Table 1 in the online-
only Data Supplement). All participants aged 19–69 years in 
the 2009 and 2018 surveys reported headache characteristics 
and accompanying symptoms, and so we could diagnose all 
migraine cases that met the diagnostic criteria. 
Migraine prevalence
In the 2009 survey, 91 respondents [6.0%, 95% confidence 
interval (CI)=4.8–7.2%] were classified as having migraine, 
while 114 respondents (5.2%, 95% CI=4.1–5.9%) were clas-
sified as having migraine. in the 2018 survey. The migraine 
prevalence did not differ significantly between the two sur-
veys (p=0.492).
Clinical characteristics of migraine
The monthly headache frequency and the score for the head-
ache intensity on a visual analogue scale did not differ signif-
icantly between the surveys. Unilateral pain, pulsating qual-
80  J Clin Neurol 2021;17(1):77-85
Changes in Migraine in Korea from 2009 to 2018JCN
ity, and vomiting were more prevalent in 2018 than in 2009, 
while aggravation by movement was more prevalent in 2009 
(Table 1). 
Impact of headache among individuals with 
migraine
The proportion of subjects with a substantial-to-severe head-
ache impact (HIT-6 score ≥56) was marginally larger in the 
2018 survey than in the 2009 survey [42.1% (48/114) vs. 29.7% 
(27/91), p=0.066] (Fig. 1). 
Disability from headache among individuals with 
migraine
In the 2009 survey, 11.0% (10/91) of individuals with migraine 
reported that they had missed activity at work, school, or in 
the household during the previous 3 months because of head-
aches. Missed activity occurred on 0.3±1.0 days, while re-
duced productivity occurred on 1.4±1.4 days. 
In the 2018 survey there were 1.1±2.9 days of missed ac-
tivity among the individuals with migraine, while there were 
0.8±2.8 days with reduced activity. The number of days with 
missed activity was significantly larger in the 2018 survey 
than in the 2009 survey (p=0.013). The number of days with 
reduced productivity did not differ significantly between the 
two surveys (p=0.679) (Table 2). 
Table 1. Clinical characteristics of individuals with migraine in the 







Age, years 41.8±11.2 43.1±12.8 0.465
Monthly headache frequency 1.0 [0.4–4.0] 0.8 [0.3–3.0] 0.583
Headache severity, VAS score 6.0 [5.0–7.0] 6.0 [5.0–7.0] 0.747
Headache intensity
Mild 20 (22.0) 19 (16.7) 0.336*
Moderate 58 (63.7) 73 (64.0)
Severe 13 (14.3) 22 (19.3)
Unilateral location 50 (54.9) 78 (60.9) 0.529
Pulsating quality 51 (56.0) 89 (78.1) 0.365
Aggravation during routine 
  physical activity
62 (68.1) 56 (49.1) 0.005
Nausea 82 (90.1) 102 (89.5) 0.784
Vomiting 28 (30.8) 52 (45.6) 0.028
Photophobia 41 (45.1) 44 (38.6) 0.330
Phonophobia 54 (59.3) 63 (55.3) 0.737
Osmophobia 47 (51.6) 45 (39.5) 0.104
Data are mean±standard-deviation, median [interquartile range], or n 
(%) values. 
*Comparison of the proportion with moderate-to-severe headache in-
tensity, †Categorical variables were compared using linear regression anal-
yses while adjusting for sex and age (in years, as a continuous variable), 
and numerical variables were compared using logistic regression analy-
ses while adjusting for age and sex.















Fig. 1. Impact of headache as assessed using the HIT-6 among indi-
viduals with migraine in the 2009 Korean Headache Survey and the 
2018 Korean Sleep-Headache Survey. HIT-6 scores: little to no impact, 
<50; some impact, 50–55; substantial impact, 56–59; severe impact, 
≥60. HIT-6: Headache Impact Test-6.
Table 2. Headache-related disability of individuals with migraine in 







Missed activity (days/3 months)
0 80 (87.9) 77 (67.5) 0.001†
1–2 5 (5.5) 27 (23.7)
3–5 5 (5.5) 5 (4.4)
≥6 0 (0.0) 5 (4.4)
No response 1 (1.1) 0 (0.0)
Duration 0.3±1.0 1.1±2.9 0.013*
Reduced productivity (days/3 months)
0 67 (73.6) 92 (80.7) 0.228†
1–2 11 (12.1) 12 (10.5)
3–5 10 (11.0) 8 (7.0)
≥6 0 (0.0) 2 (1.8)
No response 3 (3.3) 0 (0.0)
Duration 1.4±1.4 0.8±2.8 0.679*
Data are n (%) or mean±standard-deviation values. 
*Compared using linear regression analyses while adjusting for sex and 
age (in years, as a continuous variable), †Comparison of the proportion 
of having missed activity or fewer productivity days using logistic re-
gression analyses while adjusting for age and sex, ‡Three individuals 
with migraine did not report the number of days with missed activity, 
and one individual with migraine did not report the number of days with 
reduced activity in the 2009 survey. All individuals with migraine report-
ed the number of days with missed activity and reduced activity in the 
2018 survey.
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Medical consultations and treatment patterns
Lifetime medical consultations for headache were reported 
by 30.8% (28/91) and 34.2% (39/114) of individuals with mi-
graine in the 2009 and 2018 surveys, respectively (p=0.615). 
The treatment patterns of the migraine participants are 
summarized in Table 3. The proportions of patients with no 
treatment, treatment with OTC medications, treatment at 
traditional Korean medical clinics, treatment by alternative 
medicine other than traditional Korean medicine, and treat-
ment by visiting clinics or hospitals did not differ significant-
ly between the 2009 survey and 2018 survey.
DISCUSSION
This study compared survey data from 2009 and 2018 with 
the aim of identifying changes in migraine prevalence, dis-
ability, impact, and treatment in Korea. We found that 1) the 
migraine prevalence did not differ significantly between the 
2009 survey and 2018 survey, 2) disability due to missed 
activity was more common in 2018 than in 2009, whereas 
there was no significant difference in disability due to de-
creased productivity, and 3) there was no significant change 
in medical consultations or treatment patterns over the 
9-year study period. 
Several studies have examined the serial 1-year prevalence 
of migraine, and most studies involving adult populations 
have found this to be stable. Four nationwide surveys of the 
USA population aged 12 years or older showed that the mi-
graine prevalence was stable over a 23-year period: 12% in 
1989, 13% in 2001, 12% in 2005, and 14% in 2012.5,21-23 A Dan-
ish study of people aged 25–36 years similarly found a stable 
migraine prevalence over a 12-year period: 11% in 1989 and 
15% in 2001.8 However, divergent results have been obtained 
among adolescents. A Norwegian study of adolescents dem-
onstrated stable migraine prevalence over a 4-year period 
(7.2% in 1997 and 8.5% in 2001),24 whereas one in Taiwan 
found that the migraine prevalence increased significant 
over a 2-year period, from 5.2% to 7.4%. The present study 
included an adult population aged 19–69 years and showed 
a stable 1-year migraine prevalence over a 9-year period, in-
dicating that the data obtained in the two analyzed surveys 
are reliable. 
Some studies have evaluated longitudinal changes in head-
ache-related disability in individuals with migraine, and found 
small changes over time. The American Migraine Prevalence 
and Prevention (AMPP) study in 2004 and the Chronic Mi-
graine Epidemiology and Outcomes (CaMEO) study in 2012 
were nationwide studies conducted in the USA that adopted 
the same headache classification strategies and headache-
disability assessment instrument [Migraine Disability Assess-
ment (MIDAS)]. The proportion of subjects with moderate-
to-severe disability (MIDAS score >10) increased slightly over 
8 years among those with episodic migraine (AMPP: 23.0% 
of males and 31.8% of females; CaMEO: 26.7% of males and 
37.9% of females) and those with chronic migraine (AMPP: 
66.9% of males and 78.9% of females; CaMEO: 71.0% of males 
and 82.6% of females).25 However, these studies did not an-
alyze differences in headache-related disability. Also, these 
studies were based in the USA, and longitudinal changes in 
headache-related disability from migraine have never been 
reported for other regions. The present study is the first to 
perform statistical analyses of differences in disability and 
identify longitudinal changes in headache-related disability 
in individuals with migraine in Asia, which accounts for more 
than half of the world’s population. 
We found that disability due to missed activity was more 
common in the 2018 survey than in the 2009 survey, where-
as the prevalence of disability due to decreased productivity 
did not differ significantly between the two surveys. Consid-
ering that missed activity represents a greater loss than de-
creased productivity, the overall disability from migraine 
might have been greater in 2018 than in 2009. The underly-
ing reasons for the changes observed in headache-related 
disability in individuals with migraine remain unknown. The 
present study found that the prevalence and clinical features 
of migraines did not differ significantly over the 9-year study 
period. These findings suggest that increased migraine-relat-
ed disability can be attributed to changes in sociodemograph-
ic factors rather than changes in the prevalence or clinical fea-
tures of migraine. 
The per-capita gross domestic product in Korea increased 
by 171% from 2009 to 2018 (18,299 USD in 2009 and 31,370 
USD in 2018).26 Such economic growth can lead to social 
change, which may increase the awareness of disability from 
headache. The Global Burden of Disease (GBD) study per-
formed in 2015 found that the burden of migraine (quanti-
fied as disability-adjusted life years) increased with the so-
ciodemographic index.3 Another study found that disability 
Table 3. Headache treatment patterns among individuals with mi-







No treatment 29 (33.0) 30 (26.3) 0.298
OTC medications 47 (50.0) 62 (54.4) 0.533
Traditional Korean medical clinic 3 (3.3) 4 (3.5) 1.000
Alternative medicine 0 (0.0) 4 (3.5) 0.131
Clinics or hospitals 17 (19.8) 20 (17.5) 0.682
Data are n (%) values.
OTC: over-the-counter.
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from migraine is greater in high-income countries than in 
low-income countries.27 
Another possible explanation is changes in the population 
composition. The mean age of the Korean population was 
37.4 years in 2009, which increased to 41.7 years in 2018,28 
and this could affect disability from migraine. The GBD study 
in 2015 found that the global number of years of life lived 
with disability from migraine was largest among those aged 
40–45 years.3 The two survey samples assessed in the pres-
ent study showed different age distributions, which reflect-
ed the change in the composition of the population over the 
9-year study period (Supplementary Table 1 in the online-
only Data Supplement). The increase in the mean age resulted 
in more participants with migraine being in their 40s, which 
might have increased the prevalence of disability. The mean 
age of individuals with migraine in the 2018 survey was nu-
merically higher than that in the 2009 survey, although the 
difference was not statistically significant (Table 1). The small 
number of individuals with migraine is a possible reason for 
the lack of a statistical difference, and so further studies with 
larger samples may clarify the association between age and 
migraine-related disability. The present study was designed 
to compare the prevalence of and disability from migraine 
between the 2009 survey and 2018 survey conducted in Ko-
rea, and so we did not adjust for age when comparing the 
migraine prevalence between the two surveys. 
Temporal increases in medical consultations for migraine 
have been found in previous studies. For example, the rate 
of medical consultations for migraine in the USA was 16% 
in 1984, 47% in 1999,4,29 and 80% in 2016.9 Although not sig-
nificantly different, the rate of medical consultations for mi-
graine was higher in our 2018 survey than in the 2009 survey. 
Medical consultations can be affected by efforts of relevant 
organizations for disease recognition, socioeconomic status, 
and the medical system. The Korean Headache Society (KHS) 
was founded in 1999. The KHS conducted a campaign to in-
crease the awareness of distress, disability, and treatment of 
migraine in 2015 using public lectures, broadcasting, social 
network services, web pages, and other types of media.30 At 
the time of the 2018 survey (i.e., only 3 years after the start 
of the KHS campaign), there was no major change in the rate 
of medical consultations. However, we expect further increas-
es in medical consultations for migraine, which may lead to 
increases in the rates of diagnosing and treating migraine, 
which may ultimately reduce the burden of migraine.31
The Korean government implemented a National Health 
Insurance system for all citizens in 1989. However, the acces-
sibility of hospitals is partly affected by economic status due 
to the need to make visit copayments, and so the economic 
status of individuals could influence whether they seek medi-
cal consultations.32 Recent improvements in the economic 
status in Korea could increase the number of medical con-
sultations. 
The 1-year migraine prevalence rates in Korea in the 2009 
and 2018 surveys were 6.0% and 5.2%, respectively, which 
are lower than those reported for European (10–25%) and 
North American (9–16%) countries.33 The 1-year prevalence 
of migraine in Asian countries has been reported to range 
between 4.7% and 9.1%.34 Therefore, the prevalence of mi-
graine in Korea found in the present study was similar to those 
reported for other Asian countries. Possible reasons for the 
migraine prevalence being lower in Asian countries are the 
low rate of obesity, dietary factors, and ethnicity differences. 
Obesity has been associated with a higher migraine preva-
lence,35 and the prevalence of obesity is lower in Asian coun-
tries than in Western countries.36 Moreover, a low-fat diet was 
found to reduce the severity of migraine, and the dietary fat 
consumption is lower in Asian than Western countries.37,38 Fi-
nally, a lower migraine prevalence among Asian communi-
ties compared with other global ethnic groups has been con-
sistently reported in the USA.39
Most of the headache characteristics and accompanying 
symptoms in individuals with migraine were similar in the 
two surveys. However, a unilateral location, pulsating qual-
ity, and vomiting were more prevalent in the 2018 survey, 
whereas aggravation during routine physical activity was more 
prevalent in the 2009 survey. We assessed these features us-
ing the same questions and adopted a two-stage clustered ran-
dom sampling method when analyzing both surveys. There 
had been no major change in language use in Korea between 
2009 and 2018, and so it is difficult to identify exactly why these 
features changed significantly over the 9-year study period.
Migraine aura reportedly affects approximately 30% of 
individuals with migraine,40 and it differs in terms of trigger-
ing factors, female-to-male ratio, and comorbidity profiles.40-43 
Although migraine aura is a distinct subtype of migraine, in-
adequate epidemiological data on migraine with aura were 
available owing to difficulties in evaluating this condition in 
population-based studies.9 At the time of the initial survey in 
2009, there was no valid instrument for assessing aura symp-
toms, and the survey did not include questions regarding aura 
symptoms. We therefore could not compare aura symptoms 
between the two surveys. In the future we plan to conduct ep-
idemiological studies on prevalence, comorbidities, and mi-
graine-related disability using a valid instrument for assess-
ing migraine with aura.
Migraine-related disability is affected by various comor-
bidities.44 Psychiatric comorbidities such as anxiety and de-
pression are common in migraine patients and are associat-
ed with severe migraine-related disability.45 Fibromyalgia 
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(FM) is a chronic pain condition that is common among mi-
graine patients. The MIDAS score (reflecting the degree of 
migraine-related disability) was found to be higher in mi-
graine patients with FM that in those without FM.46 Howev-
er, the 2009 survey analyzed in the present study focused on 
the prevalence of and disability from headache, and did not 
include questions allowing the identification of comorbidi-
ties such as anxiety, depression, and FM. This meant that we 
could not compare the factors associated with migraine-re-
lated disability between the two surveys. Identifying the fac-
tors affecting migraine-related disability is important for re-
ducing the burden of migraine, and these factors may vary 
with the socioeconomic status.47 Further studies identifying 
the factors associated with migraine-related disability are 
needed in Korea.
The present study had several limitations. First, although 
this study used data from two nationwide surveys with large 
samples that were consistent with the population distribu-
tion in Korea, the smallness of the samples in some of the 
subgroups could have negatively affected the analyses. Sec-
ond, we did not analyze the use of migraine-specific medi-
cations and preventive treatment. Triptans and ergot deriv-
atives are migraine-specific medications that are effective at 
treating migraine attacks. Preventive treatment can reduce 
the occurrence of migraine attacks. Migraine-specific med-
ications and preventive treatment can be more effective at 
reducing the burden of migraine than analgesic treatment 
alone. Third, the cooperation rate in the 2009 survey was 
37.2%, and we did not evaluate the cooperation rate in the 
2018 survey.12 Nevertheless, we used a similar two-stage clus-
tered random sampling method in both surveys. We assume 
that the cooperation rate in the 2018 survey would have been 
similar to that in the 2009 survey. The age and sex distribu-
tions in the 2009 and 2018 surveys were similar to those in 
the total population of Korea, and it was estimated that the 
sampling errors were low for both surveys. Furthermore, the 
1-year prevalence of migraine in the present study was sim-
ilar to the prevalence rates found in previous studies per-
formed in Asian countries.34 Therefore, we can assume that 
the 2009 and 2018 surveys employed valid sampling tech-
niques. Fourth, we used two questions to assess migraine-
related disability regarding missed activity and decreased 
productivity at work, school, or in the household. The MIDAS 
is a widely used instrument for the measurement of disabil-
ity from migraine that comprises five items: 1) missed days 
at work or school, 2) decreased productivity days at work or 
school, 3) missed days for housework, 4) decreased produc-
tivity days for housework, and 5) missed days for family, so-
cial, or leisure activities during the previous 3 months.48,49 Thus, 
our two questions related to disability assessment encom-
passed four items of the MIDAS. Although we did not assess 
migraine-related disability in family, social, or leisure activ-
ities, the present study could compare disability levels dur-
ing work, school, and housework between 2009 and 2018. 
Notwithstanding the above limitations, the present study 
had several strengths. First, we used data from two nation-
wide surveys and found that the migraine prevalence was 
stable over 9 years, while disability from migraine increased. 
Several studies have found longitudinal changes in disability 
from migraine, but those studies did not analyze the changes 
in disability.25 The present study is the first to show a signifi-
cant increase in disability from migraine over time. Second, 
we assessed migraine symptoms in addition to its prevalence, 
impact, and migraine-related disability. We found that mi-
graine-related disability was greater in the 2018 survey de-
spite migraine symptoms being similar in the 2009 and 2018 
surveys.5,21,25 Third, most studies investigating changes in 
migraine prevalence and disability have been conducted in 
North American and European countries, and there have been 
very few studies of changes in migraine prevalence and dis-
ability in other regions. The present study is the first to inves-
tigate changes in the prevalence of and disability from mi-
graine in Korea; this is an important distinction, since the 
prevalence and symptoms of migraine in Asian countries 
differ somewhat from those in Western countries.34
In conclusion, we have analyzed data from two nationwide 
population-based surveys on the prevalence, disability, and 
impact of migraine as well as migraine-related medical con-
sultations and treatment patterns in 2009 and 2018. The two 
surveys used similar sampling processes and the same eval-
uation strategies, and these have demonstrated that the prev-
alence of migraine was stable, whereas the level of migraine-
related disability due to missed activity was higher in 2018 
than in 2009. The measured rate of medical consultations 
was also higher in the 2018 survey than the 2009 survey, but 
this difference was not statistically significant. Treatment pat-
terns did not differ significantly between the two surveys. 
The data and conclusions presented here can be used to 
improve the detection and treatment of migraine worldwide, 
especially to increase public awareness about its prevalence 
and treatment outcomes. 
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